Audentes Therapeutics, Inc. (BOLD) Reaches $37.70 After 8.00% Down Move; Last Week Deckers Outdoor (DECK) Coverage

May 18, 2018 - By Marguerite Chambers

Deckers Outdoor Corporation (NYSE:DECK) Logo

Among 24 analysts covering Deckers Outdoor (NYSE:DECK), 5 have Buy rating, 3 Sell and 16 Hold. Therefore 21% are positive. Deckers Outdoor had 92 analyst reports since July 31, 2015 according to SRatingsIntel. The firm earned “Market Perform” rating on Monday, November 2 by Telsey Advisory Group. Buckingham Research maintained the stock with “Neutral” rating in Friday, February 2 report. The stock of Deckers Outdoor Corporation (NYSE:DECK) has “Buy” rating given on Friday, October 6 by Stifel Nicolaus. The firm has “Buy” rating by Stifel Nicolaus given on Friday, November 11. Stifel Nicolaus maintained the shares of DECK in report on Friday, July 28 with “Buy” rating. Citigroup downgraded Deckers Outdoor Corporation (NYSE:DECK) on Friday, May 27 to “Neutral” rating. The stock of Deckers Outdoor Corporation (NYSE:DECK) has “Hold” rating given on Friday, May 26 by Susquehanna. On Tuesday, March 29 the stock rating was maintained by Citigroup with “Buy”. The stock of Deckers Outdoor Corporation (NYSE:DECK) has “Outperform” rating given on Friday, February 3 by Telsey Advisory Group. The rating was maintained by Jefferies on Friday, September 1 with “Buy”. See Deckers Outdoor Corporation (NYSE:DECK) latest ratings:

18/04/2018 Broker: Tigress Financial Old Rating: Buy New Rating: Neutral Downgrade
18/04/2018 Broker: Buckingham Research Old Rating: Neutral New Rating: Neutral New Target: $95 Reinitiate
12/03/2018 Broker: Pivotal Research Old Rating: Buy New Rating: Hold Old Target: $80 Downgrade
02/02/2018 Broker: Canaccord Genuity Old Rating: Buy New Rating: Buy Old Target: $100 New Target: $110 Maintain
02/02/2018 Broker: Jefferies Rating: Hold New Target: $93.0 Maintain
02/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $107.0 Maintain
02/02/2018 Broker: Buckingham Research Old Rating: Neutral New Rating: Neutral Old Target: $73 New Target: $89 Maintain
02/02/2018 Broker: Robert W. Baird Rating: Hold New Target: $108.0 Maintain
30/01/2018 Broker: Pivotal Research Rating: Buy New Target: $102.0
29/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $100.0 Maintain

The stock of Audentes Therapeutics, Inc. (NASDAQ:BOLD) is a huge mover today! The stock decreased 8.92% or $3.69 during the last trading session, reaching $37.7. About 643,803 shares traded or 63.00% up from the average. Audentes Therapeutics, Inc. (NASDAQ:BOLD) has risen 72.67% since May 18, 2017 and is uptrending. It has outperformed by 61.12% the S&P500.The move comes after 9 months negative chart setup for the $1.39B company. It was reported on May, 18 by Barchart.com. We have $34.68 PT which if reached, will make NASDAQ:BOLD worth $110.80M less.

Deckers Outdoor Corporation, together with its subsidiaries, designs, markets, and distributes footwear, apparel, and accessories for casual lifestyle use and high performance activities. The company has market cap of $3.26 billion. It offers premium footwear under the UGG brand name; sandals, shoes, and boots under the Teva brand name; and sidewalk surfers shoe, and yoga mat and beer cozy sandal collections under the Sanuk brand name. It has a 42.31 P/E ratio. The firm also provides running footwear under the Hoka brand name; and fashion casual footwear using sheepskin and other plush materials under the Koolaburra brand.

More important recent Deckers Outdoor Corporation (NYSE:DECK) news were published by: Globenewswire.com which released: “Detailed Research: Economic Perspectives on First American, Greenhill & Co., Acorda Therapeutics, Deckers Outdoor …” on May 15, 2018, also Investorplace.com published article titled: “7 Consumer Stocks to Sell Now”, Streetinsider.com published: “Marcato Capital Shows New Stakes in Astec Industries (ASTE), Univar (UNVR) (more…) – 13f” on May 15, 2018. More interesting news about Deckers Outdoor Corporation (NYSE:DECK) was released by: Streetinsider.com and their article: “Deckers Outdoor (DECK) Appoints William McComb to Board of Directors” with publication date: April 30, 2018.

Since February 2, 2018, it had 0 insider purchases, and 8 insider sales for $3.78 million activity. Another trade for 863 shares valued at $80,234 was sold by Lafitte David E.. $238,778 worth of Deckers Outdoor Corporation (NYSE:DECK) was sold by Powers David on Wednesday, February 7. O’Donnell Andrea sold $208,456 worth of stock. GEORGE THOMAS sold $712,289 worth of stock. Barsa Karyn Odette sold $101,448 worth of stock. Shares for $2.32 million were sold by PERENCHIO JOHN G.

The stock increased 2.04% or $2.05 during the last trading session, reaching $102.6. About 351,714 shares traded. Deckers Outdoor Corporation (NYSE:DECK) has risen 61.55% since May 18, 2017 and is uptrending. It has outperformed by 50.00% the S&P500.

Investors sentiment decreased to 1.2 in 2017 Q4. Its down 0.13, from 1.33 in 2017Q3. It turned negative, as 24 investors sold Deckers Outdoor Corporation shares while 76 reduced holdings. 47 funds opened positions while 73 raised stakes. 33.56 million shares or 5.60% more from 31.78 million shares in 2017Q3 were reported. Apg Asset Management Nv holds 0.01% of its portfolio in Deckers Outdoor Corporation (NYSE:DECK) for 121,400 shares. North Star Invest Management Corp has 0% invested in Deckers Outdoor Corporation (NYSE:DECK). London Of Virginia holds 1.09 million shares. Columbia Asset Mngmt stated it has 3,324 shares. Renaissance holds 0.02% of its portfolio in Deckers Outdoor Corporation (NYSE:DECK) for 275,900 shares. Aviance Capital Ltd Llc reported 0.25% of its portfolio in Deckers Outdoor Corporation (NYSE:DECK). Chicago Equity Limited Company holds 0.08% in Deckers Outdoor Corporation (NYSE:DECK) or 31,465 shares. Hightower Advsrs Ltd Liability stated it has 0% of its portfolio in Deckers Outdoor Corporation (NYSE:DECK). Florida-based Eagle Asset Management has invested 0.07% in Deckers Outdoor Corporation (NYSE:DECK). Frontier Capital Mgmt Limited Liability Com, a Massachusetts-based fund reported 431,541 shares. Kennedy Inc owns 0.11% invested in Deckers Outdoor Corporation (NYSE:DECK) for 73,507 shares. State Teachers Retirement Systems has 0.01% invested in Deckers Outdoor Corporation (NYSE:DECK). Voya Mngmt Ltd Llc stated it has 39,296 shares or 0.01% of all its holdings. Moreover, State Board Of Administration Of Florida Retirement System has 0% invested in Deckers Outdoor Corporation (NYSE:DECK). Barclays Public Limited reported 0% stake.

Audentes Therapeutics, Inc., a biotechnology company, focuses on developing and commercializing gene therapy products for patients suffering from diseases caused by single gene defects in the United States. The company has market cap of $1.39 billion. The firm is developing AT132 for the treatment of X-linked myotubular myopathy; AT342 for the treatment of crigler-najjar syndrome type 1; AT982 for the treatment of pompe disease; and AT307 for the treatment of the CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia. It currently has negative earnings. Audentes Therapeutics, Inc. has a collaboration with the University of Pennsylvania for the treatment of Crigler-Najjar.

More notable recent Audentes Therapeutics, Inc. (NASDAQ:BOLD) news were published by: Seekingalpha.com which released: “Audentes Therapeutics: Key Program Updates” on May 12, 2018, also Seekingalpha.com with their article: “Audentes Therapeutics’ Upcoming Catalysts” published on May 03, 2018, Stockhouse.com published: “48 Biggest Movers From Yesterday” on May 18, 2018. More interesting news about Audentes Therapeutics, Inc. (NASDAQ:BOLD) were released by: Streetinsider.com and their article: “Audentes Therapeutics (BOLD) Announces Continuing Positive Data from First Dose Cohort of ASPIRO” published on May 16, 2018 as well as Benzinga.com‘s news article titled: “Benzinga’s Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More” with publication date: May 17, 2018.

Deckers Outdoor Corporation (NYSE:DECK) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>